Skip to content

Clinical Study on the Effects of Ciprofol on Perioperative Lung Injury and NETs Formation in Elderly Patients

Clinical Study on the Effects of Ciprofol on Perioperative Lung Injury and NETs Formation in Elderly Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105560
Enrollment
Unknown
Registered
2025-07-07
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Pulmonary Injury

Interventions

Propofol group (group B):Anesthesia induction propofol 1.5-2.5 mg/kg, anesthesia maintenance propofol 4-6 mg · kg-1 · h-1
Cyclophenol group (H group):Anesthesia induced cyclosporine 0.4-0.6 mg/kg, anesthesia maintenance cyclosporine 0.8-1.2 mg · kg-1 · h-1

Sponsors

The Second Norman Bethune Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.ASA I-III 2.Aged 60-75 years 3.Surgery duration >=120 minutes 4.With informed consent from patients and their families

Exclusion criteria

Exclusion criteria: 1.Patients with severe systemic diseases and moderate to severe ventilatory dysfunction on preoperative pulmonary function tests. 2.Patients with intraoperative blood loss > 300 ml or those who received blood transfusions. 3.Patients who develop severe hypotension intraoperatively and show no improvement after the use of vasoactive drugs more than 3 times. 4.Patients who are transferred to the intensive care unit (ICU) postoperatively. 5.Patients who develop refractory hypoxemia intraoperatively. 6.Patients with intellectual or behavioral disorders who are unable to provide adequate informed consent. 7.Patients who are allergic to the drugs used in this study or have a history of alcohol or sedative-analgesic drug abuse. 8.Patients who voluntarily withdraw from this study before its completion or are concurrently enrolled in other studies.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;NETs generate biomarkers;LUS;Inflammatory factors;

Countries

China

Contacts

Public ContactZhao Peng

The Second Norman Bethune Hospital of Jilin University

zhaopeng8933@126.com+86 135 0430 8933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026